Genomictree

Genomictree Inc., a biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases. The company offers EarlyTect C, a screening method for early diagnosis of colorectal cancer; EarlyTect L for detection of epigenetic markers associated with lung cancer in pulmonary nodule patients; and EarlyTect B for detection of genetic and epigenetic markers associated with bladder cancer in hematuria patients. It also provides AccuraDTect SARS-CoV-2 RT-qPCR kit for vitro qualitative detection of RNA in nasopharyngeal or oropharyngeal swabs, test providers, and nucleic acid transport medium. Genomictree Inc. was founded in 2000 and is headquartered in Daejeon, South Korea.